Found: 29
Select item for more details and to access through your institution.
Real‐world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1‐ and 2‐infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 11, p. 6247, doi. 10.1002/jmv.27157
- By:
- Publication type:
- Article
Intraluminal duodenal diverticulum with refractory pancreatitis successfully treated by endoscopic diverticulectomy.
- Published in:
- Digestive Endoscopy, 2013, v. 25, n. 3, p. 336, doi. 10.1111/den.12026
- By:
- Publication type:
- Article
Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross Liver Study Group.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 2, p. 340, doi. 10.1007/s10637-023-01349-4
- By:
- Publication type:
- Article
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large‐scale multicenter retrospective study.
- Published in:
- Hepatology Research, 2023, v. 53, n. 11, p. 1059, doi. 10.1111/hepr.13947
- By:
- Publication type:
- Article
Real‐world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group.
- Published in:
- Hepatology Research, 2019, v. 49, n. 10, p. 1114, doi. 10.1111/hepr.13362
- By:
- Publication type:
- Article
Real‐world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.
- Published in:
- Hepatology Research, 2019, v. 49, n. 3, p. 264, doi. 10.1111/hepr.13246
- By:
- Publication type:
- Article
Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis.
- Published in:
- Hepatology Research, 2018, v. 48, n. 9, p. 746, doi. 10.1111/hepr.13070
- By:
- Publication type:
- Article
Long-term follow up of peginterferon-α-2a treatment of hepatitis B e-antigen (HBeAg) positive and HBeAg negative chronic hepatitis B patients in phase II and III studies.
- Published in:
- Hepatology Research, 2016, v. 46, n. 10, p. 992, doi. 10.1111/hepr.12638
- By:
- Publication type:
- Article
Effects of antiviral therapy for hepatitis C following treatment of hepatocellular carcinoma: survey findings of the Japanese Red Cross Liver Study Group.
- Published in:
- Hepatology Research, 2016, v. 46, n. 4, p. 251, doi. 10.1111/hepr.12515
- By:
- Publication type:
- Article
Risk of hepatocellular carcinoma in cirrhotic hepatitis B virus patients during nucleoside/nucleotide analog therapy.
- Published in:
- Hepatology Research, 2015, v. 45, n. 8, p. 872, doi. 10.1111/hepr.12427
- By:
- Publication type:
- Article
Augmented hepatic Toll-like receptors by fatty acids trigger the pro-inflammatory state of non-alcoholic fatty liver disease in mice.
- Published in:
- Hepatology Research, 2014, v. 44, n. 8, p. 920, doi. 10.1111/hepr.12199
- By:
- Publication type:
- Article
Dose-finding trial of tolvaptan in liver cirrhosis patients with hepatic edema: A randomized, double-blind, placebo-controlled trial.
- Published in:
- Hepatology Research, 2014, v. 44, n. 1, p. 83, doi. 10.1111/hepr.12099
- By:
- Publication type:
- Article
Real-World Data on Ramucirumab Therapy including Patients Who Experienced Two or More Systemic Treatments: A Multicenter Study.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2975, doi. 10.3390/cancers14122975
- By:
- Publication type:
- Article
The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2608, doi. 10.3390/cancers13112608
- By:
- Publication type:
- Article
Viral eradication reduces all‐cause mortality in patients with chronic hepatitis C virus infection who had received direct‐acting antiviral therapy.
- Published in:
- Liver International, 2024, v. 44, n. 11, p. 3060, doi. 10.1111/liv.16093
- By:
- Publication type:
- Article
Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 9, p. e3349, doi. 10.1093/cid/ciaa1307
- By:
- Publication type:
- Article
Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-69522-w
- By:
- Publication type:
- Article
Complex Pattern of Resistance-Associated Substitutions of Hepatitis C Virus after Daclatasvir/Asunaprevir Treatment Failure.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0165339
- By:
- Publication type:
- Article
Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Fas-mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C.
- Published in:
- British Journal of Haematology, 2000, v. 110, n. 1, p. 89, doi. 10.1046/j.1365-2141.2000.01945.x
- By:
- Publication type:
- Article
Efficacy of hepatitis C virus eradication after curative treatment for hepatocellular carcinoma in patients with advanced hepatocellular carcinoma and decreased hepatic functional reserve: A nationwide, multicentre study by the Japanese Red Cross Liver Study Group
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 7, p. 551, doi. 10.1111/jvh.13684
- By:
- Publication type:
- Article
Effect of treatment periods on efficacy of glecaprevir and pibrentasvir in chronic hepatitis C: A nationwide, prospective, multicenter study.
- Published in:
- JGH Open, 2024, v. 8, n. 4, p. 1, doi. 10.1002/jgh3.13068
- By:
- Publication type:
- Article
Necessity for surveillance for hepatocellualr carcinoma in older patients with chronic hepatitis C who achieved sustained virological response.
- Published in:
- JGH Open, 2023, v. 7, n. 6, p. 424, doi. 10.1002/jgh3.12914
- By:
- Publication type:
- Article
General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct‐acting antiviral therapy.
- Published in:
- JGH Open, 2022, v. 6, n. 7, p. 487, doi. 10.1002/jgh3.12778
- By:
- Publication type:
- Article
Real‐world long‐term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infection.
- Published in:
- JGH Open, 2022, v. 6, n. 5, p. 344, doi. 10.1002/jgh3.12749
- By:
- Publication type:
- Article
A validation study of after direct‐acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct‐acting antiviral therapy and achieved sustained virological response
- Published in:
- JGH Open, 2022, v. 6, n. 1, p. 20, doi. 10.1002/jgh3.12690
- By:
- Publication type:
- Article
Polymorphism of receptor-type tyrosine-protein phosphatase delta gene in the development of non-alcoholic fatty liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2018, v. 33, n. 1, p. 283, doi. 10.1111/jgh.13820
- By:
- Publication type:
- Article